Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 207-213 , September 2009

Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer

  • C.S. Souza, MD, PhD

      Affiliations

    • Division of Dermatology, Internal Medicine, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, 14048-900 São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 16 36022716; fax: +55 16 36330236.
    • ,
  • L.B.A. Felicio

      Affiliations

    • Division of Dermatology, Internal Medicine, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, 14048-900 São Paulo, Brazil
    • ,
  • J. Ferreira

      Affiliations

    • Institute of Physics of São Carlos, University of São Paulo, Brazil
    • ,
  • C. Kurachi

      Affiliations

    • Institute of Physics of São Carlos, University of São Paulo, Brazil
    • ,
  • M.V.B. Bentley

      Affiliations

    • Pharmaceutical Sciences School of Ribeirão Preto, University of São Paulo, Brazil
    • ,
  • A.C. Tedesco

      Affiliations

    • Philosophy and Sciences School of Ribeirão Preto, University of São Paulo, Brazil
    • ,
  • V.S. Bagnato

      Affiliations

    • Institute of Physics of São Carlos, University of São Paulo, Brazil

References 

  1. Daniell MD, Hill JS. A history of photodynamic therapy. Aust NZ J Surg. 1991;61:340–348
  2. Dougherty TJ, Gomer CG, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889–905
  3. Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin. 2007;25:5–14
  4. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497–508
  5. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrins IX: basic principles and present clinical experience. J Photochem Photobiol B Biol. 1990;6:143–148
  6. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 1997;79:2282–2308
  7. Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology—an update. Photodermatol Photoimmunol Photomed. 2005;21:142–149
  8. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146:552–567
  9. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30(2 Pt 2):264–271
  10. Braathen LR, Szeimies RM, Basset-Seguin N, et al. International Society for Photodynamic Therapy in Dermatology guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol. 2007;56:125–143
  11. Allison RR, Sibata CH, Downie GH, Cuenca RE. A clinical review for cutaneous malignancies. Photodiagn Photodyn Ther. 2006;3:214–226
  12. Ibbotson SH, Moseley H, Brancaleon L, et al. Photodynamic therapy in dermatology: Dundee clinical and research experience. Photodiagn Photodyn Ther. 2004;1:211–223
  13. Morton CA, MacKie RM, Whitehurst C, et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol. 1998;134:248–249
  14. Mosterd K, Thissen MR, Nelemans P, et al. DI Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Br J Dermatol. 2008;159(4):864–870
  15. Ackermann G, Abels C, Baumler W, et al. Simulations on the selectivity of 5-aminolaevulinic acid-induced fluorescence in vivo. J Photochem Photobiol B. 1998;47:121–128
  16. Martin A, Tope WD, Grevelink JM, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res. 1995;287:665–674
  17. Soler AM, Warloe T, Tausjo J, Berner A. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol. 1999;79:204–206
  18. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinic-based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001;145:467–471
  19. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol. 2000;142:338–339
  20. Star WM, van’t Veen AJ, Robinson DJ, et al. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up. Acta Derm Venereol. 2006;86(5):412–417
  21. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996;135:766–771
  22. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003;149:1242–1249
  23. Clark C, Bryden A, Dawe R, et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19:134–141
  24. Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. B J Dermatol. 2001;144:567–574
  25. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001;137:319–324
  26. Felício LBA, Ferreira J, Bentley MVB, et al. Topical 5-aminolevulinic acid photodynamic therapy as a treatment modality for nonmelanoma skin cancer. An Bras Dermatol. 2008;83(4):309–316
  27. Souza CS, Felício LBA, Bentley MV, et al. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa. Br J Dermatol. 2005;153:672–674
  28. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B Biol. 1995;29:53–57
  29. Haller JC, Cairnduff F, Slack G, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol. 2000;143:1270–1275
  30. Morton CA. How to optimise topical photodynamic therapy in dermatology. Photodiagn Photodyn Ther. 2006;3:112–115
  31. Grapengiesser S, Ericson M, Gudmundsson F, et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol. 2002;27:493–497

PII: S1572-1000(09)00130-6

doi: 10.1016/j.pdpdt.2009.09.001

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 3 , Pages 207-213 , September 2009

Article Tools

* Image Usage & Resolution